Lab Information

Dr. Carolyn Jack

Investigator
Centre for Translational Biology
Department of Medicine (McGill)

Research Profile

 Fundamental: 50%
 Clinical: 40%
 Epidemiology: 0%
 Evaluation: 10%
 This email address is being protected from spambots. You need JavaScript enabled to view it.
 ES1.1626
 E02.5125 (modules E, F) /  #76396

Keywords

Dermatology • Immunology • Atopic dermatitis • Immunophenotyping • T cell • Biomarkers

Team Members

Name Position
Gimenez Rivera, Vladimir Andrey Postdoc
Yanos, Katharina Research Assistant
Isola, Gaurav Research Assistant
Traversy-Drolet, Megan Medical Student
Patel, Harshita MSc Student
Bouchard, Charlie Administrative Assistant

Latest Publications

  1. Papp, K. A., Hong, C.-H., Lansang, M. P., Turchin, I., Adam, D. N., Beecker, J. R., Bissonnette, R., Gooderham, M. J., Jack, C., Joseph, M., Lynde, C. W. & Shear, N. H. (2021). Practical Management of Patients with Atopic Dermatitis on Dupilumab. Dermatology and therapy, vol. 11, p. 1805-1828.
  2. Belmesk, L., Muntyanu, A., Cantin, E., AlHalees, Z., Jack, C. S., Le, M., Sasseville, D., Iannattone, L., Ben-Shoshan, M., Litvinov, I. & Netchiporouk, E. (2021). Prominent Role of Type 2 Immunity in Skin Diseases-Beyond Atopic Dermatitis. Journal of cutaneous medicine and surgery, p. 12034754211027858.
  3. Maintz, L., Bieber, T., Bissonnette, R. & Jack, C. (2021). Measuring Atopic Dermatitis Disease Severity: The Potential for Electronic Tools to Benefit Clinical Care. The journal of allergy and clinical immunology. In practice, vol. 9, p. 1473-1486.e2.
  4. Ratnarajah, K., Le, M., Muntyanu, A., Mathieu, S., Nigen, S., Litvinov, I. V., Jack, C. S. & Netchiporouk, E. (2020). Inhibition of IL-13: A New Pathway for Atopic Dermatitis [Formula: see text]. Journal of cutaneous medicine and surgery, vol. 25, p. 315-328.
  5. Jack, C. & El Helou, T. (2017). Non-healing ulcerative paronychia. Lancet (London, England), vol. 389, p. 1740.
  6. Jack, C., Mashiko, S., Arbour, N., Bissonnette, R. & Sarfati, M. (2017). Persistence of interleukin (IL)-17A+ T lymphocytes and IL-17A expression in treatment-resistant psoriatic plaques despite ustekinumab therapy. The British journal of dermatology, vol. 177, p. 267-270.
More on PubMed 



See also

Card image
Elena
Netchiporouk


See profile
Card image
Moshe
Ben-Shoshan


See profile